These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 22490714

  • 41. Sirolimus in chronic allograft nephropathy.
    Wu MJ, Shu KH, Cheng CH, Chen CH.
    Transplant Proc; 2004 Sep; 36(7):2053-5. PubMed ID: 15518743
    [Abstract] [Full Text] [Related]

  • 42. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 43. A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.
    Zaghla H, Selby RR, Chan LS, Kahn JA, Donovan JA, Jabbour N, Genyk Y, Mateo R, Gagandeep S, Sher LS, Ramicone E, Fong TL.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):513-20. PubMed ID: 16441472
    [Abstract] [Full Text] [Related]

  • 44. Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients.
    Loar RW, Driscoll DJ, Kushwaha SS, Cramer CH, O'Leary PW, Daly RC, Mauriello DA, Johnson JN.
    Pediatr Transplant; 2013 Dec 15; 17(8):794-9. PubMed ID: 24164828
    [Abstract] [Full Text] [Related]

  • 45. De novo sirolimus-based regimen in Thai renal transplant recipients.
    Townamchai N, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, Eiam-Ong S.
    Transplant Proc; 2008 Sep 15; 40(7):2206-8. PubMed ID: 18790193
    [Abstract] [Full Text] [Related]

  • 46. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
    Hakeam HA, Al-Jedai AH, Raza SM, Hamawi K.
    Ann Transplant; 2008 Sep 15; 13(2):46-53. PubMed ID: 18566560
    [Abstract] [Full Text] [Related]

  • 47. Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation.
    Lyster H, Panicker G, Leaver N, Banner NR.
    Transplant Proc; 2004 Dec 15; 36(10):3167-70. PubMed ID: 15686720
    [Abstract] [Full Text] [Related]

  • 48. Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience.
    Lobach NE, Pollock-Barziv SM, West LJ, Dipchand AI.
    J Heart Lung Transplant; 2005 Feb 15; 24(2):184-9. PubMed ID: 15701435
    [Abstract] [Full Text] [Related]

  • 49. De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results.
    Meiser B, Buchholz S, Kaczmarek I.
    Curr Opin Organ Transplant; 2011 Oct 15; 16(5):522-8. PubMed ID: 21836511
    [Abstract] [Full Text] [Related]

  • 50. Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy.
    Chen J, Li L, Wen J, Tang Z, Ji S, Sha G, Cheng Z, Sun Q, Cheng D, Liu Z.
    Transplant Proc; 2008 Jun 15; 40(5):1411-5. PubMed ID: 18589119
    [Abstract] [Full Text] [Related]

  • 51. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
    Pageaux GP, Rostaing L, Calmus Y, Duvoux C, Vanlemmens C, Hardgwissen J, Bernard PH, Barbotte E, Vercambre L, Bismuth M, Puche P, Navarro F, Larrey D.
    Liver Transpl; 2006 Dec 15; 12(12):1755-60. PubMed ID: 17133564
    [Abstract] [Full Text] [Related]

  • 52. Conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.
    Fischereder M, Graeb C, Krüger B, Kammerl MC, Zülke C, Jauch KW, Krämer BK.
    Transplant Proc; 2006 Jun 15; 38(5):1295-7. PubMed ID: 16797286
    [Abstract] [Full Text] [Related]

  • 53. Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure.
    Groetzner J, Kaczmarek I, Meiser B, Müller M, Daebritz S, Reichart B.
    J Heart Lung Transplant; 2004 Jun 15; 23(6):770-3. PubMed ID: 15366440
    [Abstract] [Full Text] [Related]

  • 54. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
    Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T.
    Int J Cardiol; 2014 Jan 15; 171(1):15-23. PubMed ID: 24309084
    [Abstract] [Full Text] [Related]

  • 55. De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor.
    Chen KH, Lee CY, Wu FL, Yang CY, Yeh CC, Hu RH, Tsai MK.
    J Formos Med Assoc; 2015 Jun 15; 114(6):526-31. PubMed ID: 25843527
    [Abstract] [Full Text] [Related]

  • 56. Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience.
    Alarrayed SM, El-Agroudy AE, Alarrayed AS, Al Ghareeb SM, Garadah TS, El-Sharqawi SY, Al-Aradi AH, Dandi BG, Abdulla S.
    Clin Exp Nephrol; 2010 Jun 15; 14(3):248-55. PubMed ID: 20232105
    [Abstract] [Full Text] [Related]

  • 57. Prospective study of everolimus with calcineurin inhibitor-free immunosuppression after heart transplantation: results at four years.
    Engelen MA, Welp HA, Gunia S, Amler S, Klarner MP, Dell'aquila AM, Stypmann J.
    Ann Thorac Surg; 2014 Mar 15; 97(3):888-93. PubMed ID: 24206966
    [Abstract] [Full Text] [Related]

  • 58. Association of a change in immunosuppressive regimen with hemodynamic and inflammatory markers of cardiovascular disease after kidney transplantation.
    Yong K, Nguyen HD, Hii L, Chan DT, Boudville N, Messineo A, Lim EM, Dogra GK, Lim WH.
    Am J Hypertens; 2013 Jul 15; 26(7):843-9. PubMed ID: 23443728
    [Abstract] [Full Text] [Related]

  • 59. Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience.
    Hsu KH, Chou NK, Tsai MK, Chi NH, Chen YS, Yu HY, Wang CH, Ko WJ, Tsao CI, Lee PH, Wang SS.
    Transplant Proc; 2010 Apr 15; 42(3):934-7. PubMed ID: 20430208
    [Abstract] [Full Text] [Related]

  • 60. Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors.
    Barbier L, Garcia S, Cros J, Borentain P, Botta-Fridlund D, Paradis V, Le Treut YP, Hardwigsen J.
    J Hepatol; 2013 Dec 15; 59(6):1223-30. PubMed ID: 23933266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.